https://www.avient.com/company/policies-and-governance/colorant-chromatics-eu-global-email-disclaimers
Se è stato ricevuto per errore, si prega di avvisare la persona di Colorant Chromatics che ha mandato quest’e-mail e di eliminare immediatamente il messaggio e gli eventuali allegati senza copiarli o diffonderli.
https://www.avient.com/sites/default/files/2022-04/MEVOPUR LQ for Silicone Elastomers.pdf
Values reported as “typical” or stated without a range do not state minimum or maximum properties; consult your sales
representative for property ranges and min/max specifications.
Processing conditions can cause material properties to shift from the values stated in the information.
Avient products have not been designed for nor are they promoted or intended for use in:
(a) medical devices categorized by either the United States Food and Drug Administration (FDA) or the International Standards Organization (ISO) as an “implant” device; or “Permanent” as defined under
US Pharmacopoeia (USP) or ISO standards; or
(b) active implantable medical devices as defined in EU Directive 90/385/EEC as amended; or
(c) medical devices for “Long Term” use as defined in EU Directive 93/42/EEC as amended.
https://www.avient.com/products/polymer-additives/healthcare-additives/mevopur-healthcare-functional-additives
Medical devices, drug delivery devices, labware
Drug delivery devices, pharmaceutical packaging, medical equipment
In-Vitro Diagnostic (IVD) Device
https://www.avient.com/sites/default/files/resources/Application%2520Bulletin%2520Resilience%2520HC.pdf
The consequences to the medical
device manufacturer could include increases in:
• Service calls to repair damaged devices
• Warranty claims on damaged devices
• Product returns of damaged devices
TYPICAL APPLICATIONS
Below are just a few examples of the many
types of medical devices protected by rigid
polymer housings and frequently cleaned
with harsh disinfectants to fight HAI’s.
Values reported as “typical” or stated without a range do not
state minimum or maximum properties; consult your sales representative for property ranges and min/max specifications.
Processing conditions can cause material properties to shift
from the values stated in the information.
https://www.avient.com/sites/default/files/2023-03/Mevopur Healthcare Functional Additives Antistatic Application Bulletin_0.pdf
Values reported as “typical” or stated without a range do not state minimum or maximum properties; consult your sales
representative for property ranges and min/max specifications.
Processing conditions can cause material properties to shift from the values stated in the information.
It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including
the suitability of all raw materials and components used for its manufacture.
https://www.avient.com/news/new-regulatory-compliant-geon-bio-flexible-solutions
Consistent with the PolyOne No Surprises Pledge℠, reFlex 300 materials have been tested and certified by the United States Department of Agriculture’s BioPreferred® Program to be 99 percent bio-based.
In addition, specific healthcare formulations are pre-certified to meet biocompatibility requirements for United States Pharmacopeia (USP) Class VI protocols.
https://www.avient.com/news/avient-announces-phoenix-location-serve-colorworks-design-technology-center
With the addition of this Phoenix site, there are now five ColorWorks sites across the globe, including Merate (Italy), Sao Paulo (Brazil), Singapore, and West Chicago, Illinois (United States).
With the addition of ColorWorks Phoenix, we can more readily collaborate with our customers, especially those in the western part of the United States,” said Mayendran Pillay, Marketing Director, Color & Additives for the U.S. and Canada.
https://www.avient.com/sites/default/files/2021-10/remafin-ep-white-masterbatches-for-pharma-application-bulletin_0.pdf
Values reported as “typical” or stated without a range do not state minimum or maximum properties; consult your sales
representative for property ranges and min/max specifications.
Processing conditions can cause material properties to shift from the values stated in the information.
Avient products have not been designed for nor are they promoted or intended for use in:
(a) medical devices categorized by either the United States Food and Drug Administration (FDA) or the International Standards Organization (ISO) as an “implant” device; or “Permanent” as defined under
US Pharmacopoeia (USP) or ISO standards; or
(b) active implantable medical devices as defined in EU Directive 90/385/EEC as amended; or
(c) medical devices for “Long Term” use as defined in EU Directive 93/42/EEC as amended.
https://www.avient.com/company/sustainability/sustainability-report/people/community-service-engagement
Avient PAC aligns with candidates who support laws and regulations consistent with sustainable business practices and Avient’s interests, represent a state or district where an Avient facility is located and/ or are active members or leadership of key committees/positions.
In 2023, Avient PAC contributed $6,500 to federal candidates in the U.S. and $6,000 to state candidates in Ohio.
State of Ohio filings and contributions are publicly available at www.ohiosos.gov.
https://www.avient.com/investor-center/news/avient-announces-pricing-650-million-6250-senior-notes-due-2031
the United States
the United States
This news release does not constitute an offer to sell or the solicitation of an offer to buy any securities nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.